Rocket


News + Filings
Transactions
Holdings



Kariv Tomer

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/06/2023Keros Therapeutics, Inc.KROSGrantStock Option (right to buy)10k$48.79$487.9k 06/06/2023
01/30/2023Eloxx Pharmaceuticals, Inc.ELOXGrantStock Options (Right to Buy)2.9k$4.00$11.4k 01/30/2023
11/29/2022Keros Therapeutics, Inc.KROSExercise (in-the-money or at-the-money)Call Options (obligation to sell)3.5k$0.00$0.4See footnote11/29/2022
11/29/2022Keros Therapeutics, Inc.KROSExercise (in-the-money or at-the-money)Call Options (obligation to sell)1.7k$0.00$0.2See footnote11/29/2022
11/29/2022Keros Therapeutics, Inc.KROSExercise (in-the-money or at-the-money)Call Options (obligation to sell)1.9k$0.00$0.2See footnote11/29/2022
06/15/2022Eloxx Pharmaceuticals, Inc.ELOXGrantStock Options (Right to Buy)20k$0.26$5.2k 06/15/2022
06/01/2022Keros Therapeutics, Inc.KROSGrantStock Options (right to buy)8.3k$32.95$273.3k 06/01/2022
06/01/2021Keros Therapeutics, Inc.KROSGrantStock Option (right to buy)8.3k$51.48$426.9k 06/01/2021
05/19/2021Eloxx Pharmaceuticals, Inc.ELOXGrantStock Option (Right to Buy)20k$1.48$29.6k 05/19/2021
05/13/2021Eloxx Pharmaceuticals, Inc.ELOXPurchaseCommon Stock1.3M$1.35$1.7MBy Pontifax Investment Fund05/13/2021
05/13/2021Eloxx Pharmaceuticals, Inc.ELOXPurchaseCommon Stock2.6M$1.35$3.6MBy Pontifax Investment Fund05/13/2021
05/13/2021Eloxx Pharmaceuticals, Inc.ELOXPurchaseCommon Stock1.4M$1.35$1.9MBy Pontifax Investment Fund05/13/2021
05/13/2021Eloxx Pharmaceuticals, Inc.ELOXPurchaseCommon Stock592.6k$1.35$800kBy Pontifax Investment Fund05/13/2021
11/17/2020Keros Therapeutics, Inc.KROSPurchaseCommon Stock26.6k$50.00$1.3MSee footnote11/17/2020
11/17/2020Keros Therapeutics, Inc.KROSPurchaseCommon Stock13k$50.00$648.3kSee footnote11/17/2020
11/17/2020Keros Therapeutics, Inc.KROSPurchaseCommon Stock14.4k$50.00$720kSee footnote11/17/2020
11/17/2020Keros Therapeutics, Inc.KROSPurchaseCommon Stock6k$50.00$300kSee footnote11/17/2020
05/20/2020Eloxx Pharmaceuticals, Inc.ELOXGrantStock Option (Right to Buy)20k$3.39$67.8k 05/20/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries B-1 Preferred Stock169.3k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries B-1 Preferred Stock82.4k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries B-1 Preferred Stock91.5k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionCommon Stock79.7k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionCommon Stock36.9k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries B-1 Preferred Stock68.7k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries C Preferred Stock163.6k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries C Preferred Stock88.5k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries C Preferred Stock79.7k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries C Preferred Stock36.9k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSPurchaseCommon Stock194.2k$16.00$3.1MSee footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSPurchaseCommon Stock94.5k$16.00$1.5MSee footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSPurchaseCommon Stock105k$16.00$1.7MSee footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSPurchaseCommon Stock43.8k$16.00$700kSee footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries A Preferred Stock1.4M$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries A Preferred Stock663.8k$0.00$0See footnote04/13/2020
04/13/2020Keros Therapeutics, Inc.KROSConversionSeries A Preferred Stock737.2k$0.00$0See footnote04/13/2020
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy